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ABSTRACT
In Drosophila melanogaster, the expression of aden-
osine deaminase acting on RNA is regulated by
transcription and alternative splicing so that at
least four different isoforms are generated that
have a tissue-specific splicing pattern. Even
though dAdar has been extensively studied, the
complete adult expression pattern has yet to be
elucidated. In the present study, we investigate
mature transcripts of dAdar arising from different
promoters. Two predominant isoforms of dAdar
are expressed in gonads and dAdar is transcribed
from both the embryonic and the adult promoters.
Furthermore, full-length transcripts containing
the alternatively spliced exon-1 are expressed
in a tissue-specific manner. The splicing factor
B52/SRp55 binds within the alternative spliced
exon 3a and plays a role in this alternative splicing
event.
Drosophila adenosine deaminase acting on RNA (dAdar)
is an RNA editing enzyme that catalyzes the hydrolytic
deamination of adenosine to inosine. Inosine base pairs
with cytosine and is translated as if it were guanosine.
Therefore, RNA editing can alter the codon composition
and thereby increase the coding capacity of the RNA (1).
Alternative splicing and RNA editing are the main
pathways which increase proteome complexity post-
transcriptionally. Editing can alter the protein coding
sequence, thereby aﬀecting the function of the protein or
aﬀect the splicing of pre-mRNA (2–4). It can also inﬂu-
ence its own protein expression such as in the negative
autoregulation of rodent ADAR2 (4) and Drosophila
Adar (5). Moreover, the loss of Adar activity has been
shown to be important for normal behavior both in
Caenorhabditis elegans and Drosophila (6) and to be crit-
ical for mouse development (7,8).
Drosophila Adar lies at the tip of the X chromosome
within a region that resides in an ecdysone inducible chro-
mosomal puﬀ. Enhanced transcription from the 4A pro-
moter was observed during pupal development and
proposed to be due to an increase in ecdysone levels (9).
In adult ﬂies, the ovary and the supporting cells of
the oocyte were shown to be the major steroidogenic
tissue. (10).
There are multiple promoters for the dAdar gene.
Expression occurs from the 4A promoter during all the
stages of development, whereas 4B is only actively tran-
scribed from the pupal stage and in adults. The mRNAs
that are expressed encode a complex combination of alter-
native spliced isoforms (9). There are two mutually
excluded alternatively spliced exons, -4a, and -4b at the
50-end, in addition to alternatively spliced exons -1 and
exon 3a. Exon 3a arises from the extension of exon 3
due to the selection of a distal non-canonical GC at the
50 splice site. Inclusion or exclusion of exon 3a changes the
spacing between the dsRNA binding domain of dADAR
resulting in altered binding capability on the dsRNA tar-
gets (11). In addition, transcripts including 3a exon were
shown in vivo to lack self-editing of exon 7 that lies within
the deaminase domain. By editing its own transcript,
dADAR generates an enzyme that is catalytically less
active (5). The biological function of alternative exon-1
has yet to be determined.
Members of SR family of proteins have been shown to
be required for splice site selection. Here, we identify a
binding site for B52/SRp55 within exon 3a of dAdar and
demonstrate its role in splicing this exon. In Drosophila,
B52/SRp55 was shown to control eye development and to
regulate the alternative splicing of many transcripts
involved in brain organogenesis (12,13).
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To date, all known transcripts that are edited by
ADARs have been detected in the CNS (14). Although
editing in Drosophila occurs primarily in adult nervous
system, ADAR is expressed in other organs and the com-
plete adult expression pattern has not been deﬁned. In this
article, we investigate the expression pattern and the alter-
native splicing of dAdar in the gonads. dAdar is expressed
from both the early and late promoter and there is a
tissue-speciﬁc inclusion of exon-1.
EXPERIMENTAL PROCEDURES
Primers
dAdar Exon 2 sense
50-TACACGCACCTCTATTCACG-30
dAdar Exon 4 antisense
50-TGACCGTCAACAGTAATAGC-30
dAdar Exon -4a sense
50-TCAATAATTAGAGCAAAAAG-30
dAdar Exon -4b sense
50-GTGTGTAGTGCACTTTTGGCCAGCC-30
rp 49 sense
50-GCGGGTGCGCTTGTTCGATCC-30
rp 49 antisense
50-CCAAGGACTTCATCCGCCACC-30
egl Exon 2 sense
50-TGACGTTCGTCTTCTTCCTGG-30
egl Exon 4 antisense
50- ATCCGTCATGTTCTCGCAGCC-30
B52/SRp55 Binding site WT sense 50-GAATTAATAC
GACTCACTATAGGGAGACTACCTCGCTT
GAACAACCCACGTTTTGCATGAGTCAG-30
B52/SRp55 binding site WT as 50-TCTGACTCATGCAA
AACGTGGGTTGTTCAAGCGAGGTAG-30
B52/SRp55 Binding site MUT sense 50-GAATTAATACG
ACTCACTATAGGGAGACTACCTCGCTTGTACAT
CTCACTTTTTTTCATCAGTCAGA-30
B52/SRp55 Binding site MUT antisense
50-TCTGACTCATGAAAAAAGTGAGATGT ACAAG
CGAGGTAG-30
T7 B52/SRp55 dsRNA sense 50-GAATTAATACGACTC
ACTATAGGGAGACATCAAAAATGGCTACGGCT-30
T7 B52/SRp55 dsRNA as 50-GAATTAATACGACTC A
CTATAGGGAGAAGCTCGGTGTCATCCAACTT-30
Preparation of RNA templates for pull-down and dsRNA
experiments
RNA templates for pull-down experiments were made by
annealing the oligonucleotides listed above, that encode a
T7 polymerase sequence followed by either the wild-type
or mutant binding site for B52/SRp55. The annealed
oligos were then transcribed with T7 RNA Polymerase
(Stratagene) as previously described (15). Two speciﬁc oli-
gonucleotides also containing a T7 polymerase sequence
were used to amplify 426 bp of B52/SRp55 with cDNA
from S2 cells for the dsRNA experiment. The ampliﬁed
product was then puriﬁed and 5 mg of DNA was tran-
scribed with T7 Megascript kit (Ambion). The two RNA
strands were annealed in 100mM Tris–HCl, 10mM
MgCl2 50mM NaCl, 1mM dithiothreitol by incubating
at 658C for 20min followed by a slow cooling to room
temperature.
Drosophila stock
All RT–PCR experiments were performed with Oregon R
ﬂies, obtained from the Bloomington Stock Center. The
stock was maintained on standard cornmeal–agar medium
at 258C. Ovaries, oocytes and testes were meticulously dis-
sected in 1 PBS for the light microscopy studies (see
Supplementary material), and images were taken with
the stereo microscope (Leica 12MZ 125).
Cell culture, transfections and RNAi experiment
Drosophila S2 cell lines were cultured in Schneider’s
Drosophila media (GIBCO) with glutamax (Invitrogen)
supplemented with 10% fetal bovine serum and gentami-
cin (100mg/ml) at room temperature. For the RNAi
experiments, 15 mg of dsRNA speciﬁc for B52/SRp55
were transfected into S2 cells that were plated at 1 106/
well in six-well culture dishes with Fugene 6 Transfection
Reagent (Roche). The cells were maintained in culture for
3 days before RNA was extracted.
RNA extraction and RT–PCR
Total RNA was prepared with TRI Reagent (Sigma
Aldrich) from cultured S2 cells or from homogenized sam-
ples that had been dissected from ﬂies. cDNA was synthe-
sized with First Strand cDNA kit (Amersham Pharmacia)
with random-hexamer primers. PCR products were sepa-
rated by electrophoresis on an agarose gel and visualized
by staining with ethidium bromide. To amplify the alter-
native spliced region within exon 3/3a, RT–PCR was
performed with dAdar exon 2 as sense primer, and dAdar
exon 4 as antisense primer. To amplify the dAdar -4a/-4b
spliced region, primer speciﬁc for either exon -4a or -4b
were used as sense primer and exon 4 as antisense.
The PCR conditions were the following: 948C for 3min
for the initial denaturation, 948C for 30 s, 558C for 30 s,
728C for 50 s for 35 cycles and 728C for 7min for the ﬁnal
extension. The PCRs were optimized to be in the expo-
nential phase of ampliﬁcation. The results of the transfec-
tions represent at least three independent experiments.
The relative amount of diﬀerent splice variants was quan-
tiﬁed by optical densitometry with ImageJ software
(Rasband, W.S., ImageJ, National Institutes of Health,
Bethesda, MD, USA, http://rsb.info.nih.gov/ij/, 1997–
2004). Data were expressed as percentage of mean and
SD. The signiﬁcance of diﬀerences was determined by
Student’s t-test and P< 0.05 was considered to be statis-
tically signiﬁcant.
RNA affinity purification and western blot analysis
RNA aﬃnity puriﬁcation was performed as previously
described (16). The immunoblots were hybridized with
mouse anti-SR antibody 1H4 (Zymed Laboratories) and
revealed with chemilumiscent detection of HRP (ECL
detection kit; Amersham-Pharmacia) followed by expo-
sure to X-ray ﬁlm (Kodak X-OMAT AR).
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RESULTS
Alternative splicing of exon 3/3a of dAdar in tagmata
Exon 3 of dAdar undergoes alternative splicing due to the
presence of two competing 50 donor splice sites (50ss), a
strong proximal consensus GT, followed by a distal non-
canonical GC. The consequence of diﬀerential 50ss choice
is that two isoforms are produced. Selection of the prox-
imal donor site results in the generation of a short iso-
form, whereas the selection of the distal site produces
the longer transcript that extends exon 3 and generates
the alternative exon 3a isoform (Figure 1a).
RT–PCR analysis was performed to determine if there
is expression of dAdar transcripts containing exon 3a in
the tagmata of ﬂies. Total RNA was prepared from the
head, thorax, leg and abdomen of adult male and female
Oregon R ﬂies. RT–PCR analysis was performed with spe-
ciﬁc primers in exon 2 and 4 that were located close to the
region of interest (Figure 1b). As shown in Figure1b, the
head, thorax and leg of both male and female displayed
the same splicing proﬁle. In particular, the spliced variant
that includes exon 3a was expressed at a lower level in
comparison to the main transcript that excludes it
(Figure 1b, lanes 1–6). However, in both male and
female abdomens the opposite was observed and expres-
sion of the transcript containing 3a was the major isoform
(Figure 1b, lanes 7 and 8). Therefore, these results dem-
onstrate that the alternative splicing of exon 3/3a of dAdar
in the tagmata is regulated.
The adult abdomen has a diﬀerent embryological origin
from the rest of the body as it is derived from nests of
histoblasts located in the embryonic and larval epidermis.
This is also the compartment where the gonads are
located. Therefore, we investigated the alternative splicing
of Adar within the abdomen. Abdomens were microdis-
sected and the testis and ovary were isolated. By RT–PCR
analysis, we found the same splicing pattern as previously
observed for the whole abdomen of the ﬂies (Figure 1c,
lanes 1 and 3). The expression pattern of dAdar exon 3/3a
transcripts from the body of ﬂies without the testis or
ovaries was analyzed as a control. As it is clearly shown
in Figure 1c, the gonads have a speciﬁc splicing proﬁle
that is distinct from the bodies, suggesting that dAdar
transcripts containing exon 3a are mainly expressed in
Drosophila gonads.
Alternative splicing of dAdar inDrosophila gonads
Transcripts of dAdar originate from either an embryonic
or an adult promoter and this generates mRNAs with two
mutually excluded exons, -4a and -4b at the 50-end,
together with a complex combination of spliced isoforms.
Figure 1. RT-PCR splicing pattern and tagmata expression of dAdar exon 3/3a. (a) Schematic representation of the D. melanogaster Adar (CG12598)
transcription unit in the region of alternative spliced exon 3/3a. Introns are shown as lines and exons as boxes. The alternative spliced exon 3a is
represented as a gray box. The dinucleotides of the proximal and distal 50ss are in bold and some of the intervening sequence of exon 3a is shown. (b)
RT–PCR analysis of the alternative splicing pattern of dAdar exon 3/3a from heads, thorax, legs and abdomens of Oregon R males and females adult
ﬂies (M, F). The gray arrows show the relative location of the primers used in the RT–PCR reaction. The two black arrows indicate the alternative
spliced products generated in the RT–PCR reaction, either including or excluding exon 3a. In the lower panel, a black arrowheads mark the position
of rp49 that is used as an internal control. (c) Detection by RT–PCR of the splicing pattern of dAdar exon 3/3a expressed in testis and ovaries (lanes
1 and 3, respectively). Lanes 2 and 4 represent the controls obtained from the male ﬂy bodies without testis and the female bodies without ovaries.
Expected band size for the longer transcript that includes exon 3a was 346 bp and for the splice product excluding 3a was 235 bp. Lane M is the 1Kb
plus DNA marker. The stacked column charts below the gels show the relative percentage of amount of exon 3a/3 spliced isoforms quantiﬁed by
optical densitometry. Gray columns indicate the exon 3a percentile, while white columns indicate the exon 3 percentile. Percentage was measured
from three independent experiments; average with SD is shown.
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Four major isoforms were shown to be expressed from the
early promoter (4A) that correspond to either the inclu-
sion or exclusion of the alternative exons -1 and 3a.
However, from the late promoter (4B), only two isoforms
are transcribed. By alternative splicing exon -1 is either
included or excluded, whereas exon 3a is always skipped
(Figure 2) (9).
We have analyzed the splice site selection and tissue-
speciﬁc expression of the two mutually excluded alterna-
tively spliced exons, -4a -4b in the testis and ovaries.
Promoter-speciﬁc transcripts were ampliﬁed with primers
annealing speciﬁcally to the end of either exon -4b or -4a
(Figure 3). RT–PCR analysis of exon -4b containing tran-
scripts from the testis and ovaries displayed no
major diﬀerences to their respective body controls either
including or excluding exon -1 (Figure 3a, upper panel,
lanes 1–4). However, transcripts containing both exon
-4a and exon 3a (Figure 3a, lower panel, lanes 5 and 6)
were enriched in the testis and ovaries. The alternative
exon -1 was expressed in a tissue-speciﬁc manner being
more abundant in the ovaries than in the testis
(Figure 3a, lanes 5 and 6). Direct sequencing of the RT–
PCR products conﬁrmed the exon composition. As
expected, the bodies of the ﬂies previously used as controls
express almost exclusively the two isoforms lacking exon
3a (Figure 3a, lanes 7 and 8).
In summary, these results demonstrate that in ovaries
there is a coordinated inclusion of both exon -1 and 3a
when the upstream -4a exon is chosen.
dAdar exon -4a containing transcripts are developmentally
expressed inDrosophila ovaries
The dAdar gene lies in an ecdysone inducible chromo-
somal puﬀ and an increase in dAdar transcript levels is
observed during the pupal stage (9). Moreover, signiﬁcant
levels of ecdysone are found in adult females and the nurse
cells that are the supporting cells of the oocyte, are the
major steroidogenic tissue (10).
Light microscopy images of Drosophila ovaries at days
1, 3, 5 and 10, show that in the ovary there is an increase in
the number of mature oocytes and consequently the
number of nurse cells from eclosion through to day 10
(Supplementary Figure S1). Therefore, exon 3a could be
diﬀerently expressed in the adult females during this devel-
opmental stage in the ovary. To test this hypothesis,
we microdissected the ovary and testis and analyzed the
splicing pattern of exon 3/3a by RT–PCR. This time-
course analysis revealed a signiﬁcant increase in the
spliced variants containing exon 3a in the gonads by day
3 (Figure 3b). This increased inclusion of the exon 3a in
ovaries and testis suggests an enhanced activity from the
early -4A promoter. Indeed a time-dependent increase
in the length of transcripts encoding exon 3a was observed
in the ovary but not in the testis (Figure 3c). In contrast,
we did not observe any substantial change in the splicing
pattern when we analyzed the transcripts that arise from
the adult 4B promoter (Supplementary Figure S2). These
experiments suggest that promoter choice dictates splice
site preference in ovaries.
Expression of dAdar spliced isoforms 3/3a during oocyte
development
Transcripts of dAdat1, a speciﬁc tRNA editing enzyme
was shown to be produced by nurse cells and then
loaded into the egg before fertilization (17). To determine
if dAdar behaves in a similar manner its expression was
analyzed during oocyte development.
Each ovary is composed of 16 ovarioles, in which the
developing oocyte starts its diﬀerentiation in the germar-
ium to generate an unfertilized egg after maturation. The
ovary was dissected and RNA isolated from the germar-
ium that included the earliest stages of the oocytes devel-
opment; stages 4–8, stages 10 and 11 as well as mature
unfertilized eggs (Supplementary Figure S3).
Expression of the Egalitarian gene was analyzed as a
positive control (Figure 4a, lower panel), as it is expressed
from the earliest stages of oogenesis and is required for
oocyte speciﬁcation in the germarium (18). RT–PCR anal-
ysis revealed that transcripts that both include and exclude
3a are expressed from early stages of oocyte formation
and are detected during oocyte development (Figure 4a,
upper panel). Furthermore exon -4a was also detected
during these development stages of oogenesis (Figure 4b).
Exon 3a contains a binding site for the SR proteins
B52/SRp55
B52 is the SRp55 homologue in D. melanogaster.
B52/SRp55 is an essential splicing factor required for
Drosophila development and it is known to regulate
the splicing mechanism of many transcripts involved
in brain organogenesis (12,13). The RNA binding consen-
sus sequence for B52/SRp55 has been previously identiﬁed
(19). The predicted secondary structure for the B52/SRp55
binding site is a hairpin structure with a guanosine
Figure 2. Schematic organization of the dAdar gene from the transcrip-
tional start sites to the end of exon 4. (a) Schematic representation of
the dAdar gene encompassing the region from the two promoter to the
end of exon 4. In the article, to avoid confusion, we refer to the pro-
moter with capital letters (4A and 4B), whereas -4a and -4b are the
mutually excluded exons. Exons are shown as boxes and introns as
black lines. The black and gray arrowheads mark the position of the
embryonic (4A) and adult (4B) transcriptional start sites. The black and
gray dashed lines indicate the pattern of alternative splicing that arise
from the mutually excluded alternative spliced exons -4a and -4b. The
two other alternative spliced exon (-1 and 3a) are indicated by a black
and gray box respectively. (b and c) Diagrams of the alternative splicing
composition of the main spliced variants that arise from the embryonic
and adult promoters.
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residue at the +8 position that is crucial to maintain
its structure (19). We found that this motif with the gua-
nosine residue almost perfectly matched a sequence
within exon 3a of dAdar (Figure 5a). The predicted
secondary structure for the putative B52/SRp55 binding
site within dAdar exon 3a suggests that its binding motif
lies in a loop and the +8 guanosine residue mimics its
important role in maintaining the hairpin structure
(Figure 5b).
To assess whether the B52/SRp55 is able to interact
with this putative binding motif, we performed an RNA
aﬃnity puriﬁcation followed by western blot analysis. The
substrates used were either in vitro transcribed dAdar
RNA containing exon 3a or as control mutated dAdar
exon 3a where the binding site for both B52/SRp55 and
the +8G nucleotide were disrupted by point mutations
(Figure 5a). These RNA templates were bound to adipic
acid dehydrazide agarose beads by covalent conjugation.
After incubation with Drosophila Schneider’s S2 extract,
the RNA protein complexes were separated on an
SDS–PAGE gel and then subjected to western blot analy-
sis with the antibody 1H4 that recognizes the phosphory-
lated epitope on SR proteins. As a loading control for
this experiment, an aliquot of the pulled down RNA pro-
tein complexes was visualized by staining with Coomassie
Blue (Figure 5c, left panel). As shown in Figure 5c,
right panel, only the RNA containing the wild-type
dAdar exon 3a sequence pulled down a protein that
migrated at the same molecular weight as B52/SRp55 in
the S2 extract. Therefore, B52/SRp55 could regulate the
Figure 3. Promoter choice of dAdar and analysis of alternative splice pattern in gonads. (a) In the upper panel, RT–PCR analysis of the adult -4b
alternative splicing pattern that is expressed in the testis and ovary (lanes 1 and 2) and the corresponding controls (lanes 3 and 4) is shown. In the
lower panel is the RT–PCR of the -4a alternative splicing pattern expressed in testis and ovary (lanes 5 and 6), and the corresponding controls (lanes
7 and 8). A diagram of the alternative spliced isoforms are shown on the left with their exon composition and the black and gray boxes indicate the
alternative spliced exons -1 and 3a. Exon -1 is expressed in a tissue-speciﬁc manner and is found in the ovary. The splicing pattern of dAdar
transcripts in testis and ovary (lanes 5–8) is the inverse to their controls (lanes 7 and 8). The gray arrows indicate the relative location of the primers
used in the RT–PCR. The expected band size for the -4b-Ex4 transcripts is 615 bp and 575 bp, respectively. The expected band size for the -4a-Ex4
transcripts is 608 bp for the full length, 568 bp (excluding exon-1) 497bp (excluding exon 3a) and 457bp (excluding exon-1 and exon3a). (b) A time
course performed by RT–PCR of the expression pattern of dAdar exon3/3a from male and female gonads. (c) A time course of the alternative
splicing pattern of -4a exon from male and female gonads analyzed by RT–PCR. Black arrowheads indicate the position of the constitutively
expressed rp49 rRNA used as an internal control in the lower panels of (a), (b) and (c). The stacked column charts below the gels show the relative
percentage of the spliced isoforms that was quantiﬁed by optical densitometry. On the left of each column chart, a color key indicates the diﬀerent
alternative spliced isoforms. The quantiﬁcation was performed on three independent experiments and the average with SD is shown.
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Figure 5. Exon 3a binds the alternative splicing factor B52/SRp55. (a) Schematic representation of the dAdar region encompassing exon 3/3a
showing a partial sequence of exon 3a that includes the B52/SRp55 binding site. (1) The RNA sequence found by SELEX as a high aﬃnity binding
site for B52/SRp55. (2) The RNA sequence of dAdar exon 3a used for the RNA aﬃnity technique. This RNAs contains the conserved consensus
motif for B52/SRp55 and this is shown in bold. (3) (c) Left panel, RNA-aﬃnity puriﬁcation of proteins bound to RNA encoding either wild type or
mutated exon 3a. Right panel, Western blot analysis of the bound proteins with 1H4 monoclonal antibody. The black arrow indicates phosphory-
lated B52/SRp55 that is present in S2 nuclear extract. The Beads lane is the negative control. The protein gel in the left panel is stained with
Coomassie Blue to visualize the pulled down RNA protein complexes and is a loading control for the experiment.
Figure 4. dAdar expression during the oocyte development. In (a and b) RT–PCR of dAdar in oocytes undergoing maturation to unfertilized mature
eggs is shown. The alternative spliced region exon 3/3a and transcripts originating from the 4A promoter were ampliﬁed. The gray arrows indicate
the relative location of the primers used in the RT–PCR reactions. St.4-8 and St.10-11 are the oocytes stages from which total RNA was prepared
and RT–PCR analysis was performed. Black arrowheads indicate the mRNA of the constitutively expressed egalitarian gene (Egl) which was used as
an internal control. The stacked column charts below the gels show the relative percentage of the spliced isoforms quantiﬁed by optical densitometry.
On the left site of each column chart, the color key indicates the diﬀerent alternative spliced isoforms. The quantiﬁcation was performed on three
independent experiments and the average with SD is shown.
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alternative splicing of exon 3a in Drosophila by binding
within exon 3a.
B52/SRp55 is required for the dAdar exon3/3a splicing
regulation
To demonstrate that B52/SRp55 is important for the alter-
native splicing of dAdar exon 3/3a, we took advantage of
double-stranded RNA-mediated interference for B52/
SRp55 proteins in a Drosophila cell line (20).
Transient transfection of the speciﬁc siRNA in embry-
onic Drosophila Schneider’s S2 cell line induced a strong
reduction in the B52/SRp55 levels (Figure 6a). Its speciﬁ-
city has already been demonstrated and described in Park
et al. (21). To determine whether the knockdown of B52/
SRp55 aﬀects the splicing of the third exon of dAdar gene,
cells treated with dsRNA were then probed for the splicing
of exon3/3a. The S2 cells endogenously express dAdar
mRNA that includes the exon 3a. After RNAi depletion
of B52/SRp55 there was an increased exclusion of the
exon 3a sequences (Figure 6b). Thus, our data demon-
strates that the binding of B52/SRp55 within exon 3a is
required for the inclusion of this alternative spliced exon
in the mRNA.
DISCUSSION
In this article, we describe the expression, tissue speciﬁcity
and the complex transcriptional/splicing regulatory mech-
anism of dAdar. As the biological role of RNA editing is
principally in the adult nervous system in Drosophila, to
date most of the research on the expression pattern and
the alternative splicing of dAdar has focused primarily on
the brain. Indeed, the complete adult expression pattern
has yet to be elucidated. The splicing pattern of the dAdar
transcripts in the thorax and legs resembles that already
characterized for the ﬂy brain. However, dAdar is also
expressed in the gonads where the splicing mechanism
favors the inclusion of the alternative exon 3a.
Interestingly, dAdar is expressed from both the early and
adult promoters in testis and ovaries and full-length tran-
scripts containing both alternatively spliced exons 3a and -
1 are expressed in a tissue-speciﬁc manner as this tran-
scripts is primarily expressed in the ovaries.
The alternative 3a exon is only present in transcripts
that originate from the 4A promoter. Therefore, a time
course of the expression of exon 3/3a was performed
and the number of transcripts including exon 3a was
observed to increase by day 3 after eclosion. A concurrent
increase in the number of oocytes and supporting nurse
cells was observed in the ovaries during this time course. A
direct correlation can be drawn between the use of pro-
moter 4A and the increased level of ecdysone produced by
the nurse cells. This is consistent with the dAdar locus
being located in an ecdysone inducible puﬀ region near
the BrC complex, which encodes transcription factors
that also respond to this steroidogenic hormone (22).
This increased usage of the 4A dAdar promoter was also
observed during the pupal stage as ecdysone regulates
larval development and metamorphosis (9). In adult
Figure 6. Regulation of the splicing of dAdar exon 3/3a by B52/SRp55. (a) Western blot analysis to determine the level of down regulation of
endogenous B52/SRp55 protein after knockdown with dsRNA. NE indicates HeLa nuclear extract. The black arrows indicate the molecular weight
of the SR proteins that are identiﬁed with the 1H4 monoclonal antibody. (b) RT–PCR analysis of dAdar after dsRNA knockdown of B52/SRp55 in
S2 cells. M, is the 1 kb plus DNA marker and the symbol minus, indicates the negative RT–PCR control. (c) Western blot analysis of total protein
extracts from female and male gonads during early development (days 1, 3 and 10) probed with 1H4 monoclonal antibody. NE indicates HeLa
nuclear extract. The black arrows indicate the SR proteins that are recognized with the 1H4 monoclonal antibody.
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females, ecdysone is also produced in the nurse cells in the
ovary. Therefore, we propose that enhanced activity from
the 4A promoter is a consequence of an increased level of
the ecdysone produced by these nurse cells.
As transcripts of a related protein dAdat (the Drosophila
t-RNA editing enzyme) were shown to be produced by the
nurse cells and loaded into the egg before the fertilization
(17), we wanted to determine if dAdar could be detected
during oogenesis. Full-length transcripts of dAdar were
detected from early stages in oocyte development through
to unfertilized mature eggs. One question that needs to be
address is whether the predominant transcripts expressed
in gonads are translated into functional proteins.
However, this will remain unanswered until better
dADAR antibodies are available. In Drosophila, the
oocyte nucleus has been shown to be transcriptionally
inactive during most of stages of oogenesis (23). The
embryo receives maternally provided transcriptional
input from the two other cell sources in the oocyte: the
nurse cells and the somatic follicle cells. Therefore, in the
future it will be interesting to understand the contribution
to dAdar expression both from the nurse cells and the
somatic follicle cells.
Recently, additional roles for editing enzymes have been
proposed in relation to Alu elements, siRNA and miRNA
function. ADARs can edit noncoding RNAs and can
aﬀect the processing of miRNAs such as pri-miR-142
(24) or aﬀect the seed sequence as occurs in miR-376
(25), so that the miRNA is redirected to silence a diﬀerent
set of transcripts. Therefore, it is interesting to consider
that dADAR could interact with noncoding RNAs and
retarget the silencing machinery to transcripts that are
required to be inactivated during the oocyte development.
To determine which splicing factor could regulate the
alternative splicing of exon 3/3a, we analyzed the nucleo-
tide sequence of exon 3a. The B52/SRp55 binding
sequence obtained by SELEX (19) is very similar to the
sequence we found in exon 3a that has a hairpin conﬁgu-
ration with the protein binding site exposed in a loop and
the guanosine residue that is critical for RNA structure.
We demonstrated that B52/SRp55 speciﬁcally binds
within exon 3a. Depletion of B52/SRp55 in Drosophila
S2 cell line by RNAi demonstrates that this splicing
factor controls the inclusion of the exon 3a as its down-
regulation promotes the exclusion of exon 3a. However,
we cannot conclude that the increase level of inclusion of
exon 3a present in dAdar transcripts in the gonads is due
to an increase in B52/SRp55 protein. Indeed, in testis and
ovary the expression level of B52/SRp55 does not change
during the developmental stages that have been analyzed
(Figure 6c). This result suggests that in Drosophila gonads
additional splicing factors participate in the complex splic-
ing mechanism that regulates the alternative splicing of
exon 3a. These results conﬁrm previous reports that
B52/SRp55 together with other splicing factors participate
in the recognition of the distal 50ss (20). B52/SRp55 was
previously been shown to control eye development and to
regulate the splicing of many transcripts involved in brain
organogenesis (12,13). Here, we describe a novel function
for B52/SRp55 to regulate the splicing of the exon3/3a in
Adar transcripts in testis and ovaries (26).
The inclusion or exclusion of exon 3 in dAdar tran-
scripts was demonstrated to aﬀect both the binding and
editing activity of the protein (5). In vivo no transcripts
have been isolated that contain exon 3a and are edited in
the deaminase domain. However, in vitro transcripts
including the 3a isoform were shown to have reduced
self-editing in exon 7 that lies within the deaminase
domain. In addition, the exon 3a containing transcript
introduces an additional 38 amino acids between
dsRBM 1 and dsRBM 2 that generates two distinct
enzymes. The spacing between the binding domains with
exon 3a is very similar to the distance between the binding
domains of ADAR2, whereas when this exon is excluded
the distance is reminiscence of the distance between the
dsRNA binding domains found in ADAR1. This conser-
vation in the spacing of the dsRNA binding domains sug-
gests that it is important for function. It has also been
shown that the diﬀerent isoforms of dAdar can form het-
erodimers and this can change its binding capability on the
dsRNA target (11). Therefore, in the gonads diﬀerent iso-
forms of dAdar with diﬀerent editing activity could specif-
ically edit transcripts that are expressed there and as a
consequence modify the properties of the encoded
proteins.
In ovaries, the inclusion of the alternative exon-1 results
in a protein being expressed that has an additional 12
amino acids at the amino-terminal. This exon introduces
an alternative in-frame translational start site that is pre-
ferentially transcribed from the early promoter. It has pre-
viously been shown that the use of alternative
translational starts can regulate several cytokine family
proteins whose expression level has to be ﬁne tuned to
maintain their physiological activity (16,27). Therefore,
the question arises could this be a form of regulation of
dAdar in the ovary that is in addition to autoediting?
This regulation would represent a coordinated transla-
tional–transcriptional control that regulates alternative
splicing and therefore the activity of the editing enzyme
in the ovary.
New editing targets have recently been found (28).
Several of these novel edited transcripts were shown to
be involved in ion homeostasis, cytoskeletal components
and signal transduction pathway and they may be edited
in the gonads and have a biological role there.
In the gonads, development continues throughout the
lifetime of the animal and the pathway involves the coor-
dinated division and diﬀerentiation of a large number of
cells. This site of extensive adult development probably
requires a ﬁne tune regulation of dAdar.
It is possible that the presence of diﬀerent spliced iso-
forms of dAdar, may reﬂect diﬀerences in dAdar substrate
speciﬁcity. Indeed, the tissue-speciﬁc alternative splicing
of dAdar in Drosophila gonads may expand the repertoire
of ADAR targets beyond the brain to Drosophila
gonads (29).
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